相关实验视频

Updated: Jun 18, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

铁糖酸铁补充后发生的血小板缺血症

Aljoharah A Al Saud¹, Muneerah R AlRomaizan¹, Muath A Alkhunizan¹

¹From the College of Medicine (Al Saud, AlRomaizan), Alfaisal University, and from the Department of Family Medicine and Polyclinic (Alkhunizan), King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia.

Saudi medical journal

|July 29, 2024

概括

铁的补充很少会引发免疫性血小板缺血 (ITP),这是一种导致血小板数量低的疾病. 这一案例突显了铁酸葡萄酸诱导的血小板缺血症,强调了对这种罕见的ITP原因进行进一步研究的需要.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
内部医学内部医学

背景情况:

免疫性血小板缺血 (ITP) 是一种自身免疫性疾病,其特征是血小板数量减少,增加出血风险.
铁补充是很少发现的ITP触发因素,记录的案例很少.
经常出现的ITP会带来复杂的诊断和管理挑战.

研究的目的:

报告一个独特的免疫性血小板缩病例,由铁补充引起.
为了说明 ferrous gluconate 与慢性 ITP 患者的血小板缺血之间的潜在联系.
强调在反复的ITP管理中考虑阳性原因的重要性.

主要方法:

一个54岁的男性病例报告,有复发性ITP的病史.
铁糖酸盐的使用后观察到快速的血小板缺血.
在停止铁补充剂后,对血小板计数的监测.

主要成果:

患者在开始铁糖酸盐治疗后经历了急性血栓缩.
血小板计数在停止铁糖酸盐后恢复正常.
这种反应表明,在这个人身上,铁补充和血小板缺血之间存在直接的因果关系.

结论:

铁补充,特别是铁糖酸盐,可以诱导易受ITP感染的个体的血小板缺血症.
这一案例突显了ITP的慢性和复杂病因.
需要进一步研究以阐明铁补充引起的血小板缺血的患病率和机制.

关键词:

案例报告案例报告免疫性血小板减少症.铁补充诱导的诱导铁补充

更多相关视频

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

相关概念视频

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...